Slideshow Old
The Evolution of Biosimilars from Their Beginning Until Now—And What’s Next
Chrys Kokino has been involved in the biosimilars market prior to the first biosimilar ...
The Inflation Reduction Act Passed, Now What?
In April 2022, we released an article describing proposed policies from the federal government ...
What Physicians Want from Pharma—And Where—During Diagnosis and Treatment
For life sciences commercial teams, effectively engaging physicians and supporting them with education on ...
Reaching Crucial Hispanic Patient Audiences
Health marketers learned many valuable lessons during the pandemic. Above all was the importance ...
5 Ways Your Market Access Strategy Can Create a Better-Connected Patient Experience
Market access stands at the cusp of a golden opportunity to help increase healthcare ...
Marketing to Type 2 Diabetes Patients: How Pharma Can Increase Treatment Awareness, Improve Outcomes
The rising prevalence of type 2 diabetes has attracted the attention of many major ...
Improving COVID Care Delays: How Pharma Companies Can Help Patients
The COVID pandemic indelibly altered the healthcare industry in visible, visceral ways. Not only ...
Delivering Improved Disease Awareness Through More Strategic Partnerships
Can an art installation teach you about a disease? How about a song? Or ...
4 Steps to Make Hybrid Work for Your Workplace
The virtual workplace was a two-year experiment. Now, the next one begins: hybrid work. ...
Taking the Necessary Steps to Enhance the Patient Experience
As life sciences companies continue to preach patient centricity or a patient-first approach, it ...
Two Key Questions About Patient Experience in 2022
PM360 asked industry experts what it takes to be a patient-first organization and how ...
Embedding the Patient Point of View in Everything You Do
The term “patient centricity” has been around for over a decade, and since its ...
What I Brought Home from the 2022 Chief Patient Officer Summit
Recently, industry and community patient advocacy pioneers came together for the Chief Patient Officer ...
